Stage IVA Squamous Cell Carcinoma of the Larynx
specificStage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues
7
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage IVA Squamous Cell Carcinoma of the Larynx(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 57.1 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 57.1 |
| 3 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 57.1 |
| 4 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 57.1 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 57.1 |
| 6 | University of Illinois Cancer CenterChicago, IL | 57.1 |
| 7 | Upstate Cancer CenterSyracuse, NY | 57.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →